What is the role of MRD assessment in the management of multiple myeloma patients?

International expert, Consultant Haematologist Professor Maria-Victoria Mateos gives her views on the role of minimal residual disease (MRD) assessment in clinical practice and the way in which this technique can be effectively implemented into routine care.

The views expressed in this video are those of the speaker.

UK/NP/1806/0035k - July 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.